Tree of Knowledge International Corp. (OTC:TRKWF) announced today that it has completed the acquisition of Asterion Bio Med.
Asterion has access to one of the largest healthcare systems across Canada for its education and research platform, with over 1.5 million patient visits annually through an exclusive strategic alliance agreement with Jack Nathan Medical Inc.
Currently, TRKWF produces and sells hemp-based cannabidiol (“CBD”) products in certain jurisdictions in the United States, as well as in Europe, South America and China. TOK’s CBD product line contains EVR Premium Hemp Oil, which is derived from U.S. Department of Agriculture (USDA) approved industrial hemp grown in the United States.
With the Farm Bill Passing today, this has opened up the doors for CBD companies like OTC:TRKWF.
What is equally as exciting is that Tree of Knowledge is led by an unbelievable management team, starting with the CEO Jean-Paul Gaillard, Ex-Nespresso CEO.
Under Gaillard’s leadership, Nespresso was able to achieve and generate a multibillion turnover, with some of the food and beverage industry’s highest margins and ROIC. He has worked with major multinational companies like Nestlé and Philip Morris Companies. Gaillard is most noted for the international expansion of the Marlboro Classics brand for Philip Morris.
He turned the Marlboro Classics brand into a leader in its field, and at par with its most successful competitors in the tobacco manufacturing industry. The CBD space is opening up and leaders like Gaillard and his team are positioned to quickly grab market share and have the experience to truly globalize a brand.
Needless to say, it is an exciting time for TRKWF and this is only the beginning.
Wholesalestockmarket.com has entered into an agreement with Oasis Marketing Services to host this advertorial for a fee of $2500.00 for a period starting December, 2018. We own zero shares of (OTC:TRKWF) which we purchased in the open market. We may buy or sell shares of (OTC:TRKWF) in the open market at any time, including before, during or after the advertorial.